Republic of Korea
5 Vaccines Approved for Use in Republic of Korea
Protein Subunit
RNA
Moderna
Spikevax
Approved in 86 countries
63 trials in 22 countries
Approval Source: modernatx.gcs-web.com
RNA
Pfizer/BioNTech
Comirnaty
Approved in 146 countries
80 trials in 26 countries
Approval Source: asia.nikkei.com
Non Replicating Viral Vector
Janssen (Johnson & Johnson)
Ad26.COV2.S
Approved in 111 countries
23 trials in 23 countries
Approval Source: mfds.go.kr
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Approval Source: reuters.com
9 in Clinical Trials in Republic of Korea
Protein Subunit
SK Bioscience Co Ltd
GBP510
6 trials in 6 countries
DNA
Inovio
INO-4800
9 trials in 9 countries
Non Replicating Viral Vector
Oxford/AstraZeneca
Vaxzevria
Approved in 140 countries
63 trials in 30 countries
Protein Subunit
EuBiologics Co Ltd
EuCorVac-19
2 trials in 1 country
DNA
GeneOne Life Science, Inc.
GLS-5310
4 trials in 2 countries
Replicating Viral Vector
Cellid Co
AdCLD-CoV19
2 trials in 1 country
Protein Subunit
SK Bioscience Co Ltd
NBP2001
Protein Subunit
HK inno.N Corporation
IN-B009
Non Replicating Viral Vector
Cellid Co
AdCLD-CoV19-1
1 Vaccines with Trials in Republic of Korea are No Longer Progressing
DNA
Genexine
GX-19
7 trials in 1 country